tiprankstipranks
Trending News
More News >
Tarsus Pharmaceuticals (TARS)
NASDAQ:TARS
US Market

Tarsus Pharmaceuticals (TARS) Ownership - Who Owns Tarsus Pharmaceuticals?

Compare
262 Followers

Tarsus Pharmaceuticals (TARS) Ownership Overview

3.15%20.87%50.53%12.07%13.38%
50.53% Other Institutional Investors
12.07% ETFs
13.38% Public Companies and
Individual Investors
The ownership structure of Tarsus Pharmaceuticals (TARS) stock is a mix of institutional, retail, and individual investors. Approximately 83.47% of the company’s stock is owned by Institutional Investors, 3.15% is owned by Insiders, and 13.38% is owned by Public Companies and Individual Investors.
The ownership structure of Tarsus Pharmaceuticals (TARS) stock is a mix of institutional, retail, and individual investors. Approximately 71.40% of the company’s stock is owned by Institutional Investors, 3.15% is owned by Insiders, and 12.07% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Sep 10, 2025
xxxxxxxxxxxxx
$1545612
Mar 20, 2025
xxxxxxxxxxxxx
$1163050
Mar 20, 2025
xxxxxxxxxxxxx
$321323
Mar 20, 2025
xxxxxxxxxxxxx
$363142

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Dec 31, 2025
xxxxxxxxxxxxx
$1375584
Dec 31, 2025
xxxxxxxxxxxxx
$95998322

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
2,021,261Institution4.76%127,885,183
1,937,404Institution4.56%122,579,551
1,608,863Institution3.79%101,792,762
1,172,427Institution2.76%74,179,456
859,741Insider2.03%54,395,813
772,688Institution1.82%48,887,970
633,609Institution1.49%40,088,441
472,002Institution1.11%29,863,567
426,398Institution1.00%26,978,201
385,753Institution0.91%24,406,592

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,608,863Institution3.79%101,792,762
772,688Institution1.82%48,887,970
633,609Institution1.49%40,088,441
472,002Institution1.11%29,863,567
426,398Institution1.00%26,978,201
385,753Institution0.91%24,406,592
360,530Institution0.85%22,810,733
347,133Institution0.82%21,963,105
343,579Institution0.81%21,738,243
322,485Institution0.76%20,403,626

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,270,125Institution2.99%81,973,868
961,055Institution2.26%60,805,950
422,572Institution1.00%27,272,797
331,245Institution0.78%20,957,871
283,728Institution0.67%17,951,471
188,549Institution0.44%11,837,106
186,454Institution0.44%12,033,741
137,792Institution0.32%8,718,100
103,044Institution0.24%6,519,594
95,875Institution0.23%6,187,773

FAQ

Who Owns Tarsus Pharmaceuticals (TARS)?
According to the latest TipRanks data, approximately 50.53% of the company's stock is held by institutional investors, 3.15% is held by insiders, and 13.38% is held by retail investors.
    What percentage of Tarsus Pharmaceuticals (TARS) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 50.53% of Tarsus Pharmaceuticals (TARS) stock is held by institutional investors.
      What percentage of Tarsus Pharmaceuticals (TARS) stock is held by retail investors?
      According to the latest TipRanks data, approximately 13.38% of Tarsus Pharmaceuticals (TARS) stock is held by retail investors.
        Who owns the most shares of Tarsus Pharmaceuticals (TARS)?
        Vanguard owns the most shares of Tarsus Pharmaceuticals (TARS).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.